Chemical Business NewsBase - Pharma Japan:; Teijin Pharma to launch TMX-67 in emerging countries in 2013-2014.
In: Chemical Business NewsBase (UK), 2011-01-24, S. 2
Zeitungsartikel
Zugriff:
Teijin Pharma plans to roll out its TMX-67 (febuxostat), a novel treatment for gout and hyperuricaemia, in 2013-2014 in three emerging regions: Central/South America including Brazil; member countries of the Association of South-East Asian Nations; and in the Middle East/North Africa, including Egypt. The company targets global sales of over Yen 100 bn/y, at peak, for the drug...
Titel: |
Chemical Business NewsBase - Pharma Japan:; Teijin Pharma to launch TMX-67 in emerging countries in 2013-2014.
|
---|---|
Zeitschrift: | Chemical Business NewsBase (UK), 2011-01-24, S. 2 |
Veröffentlichung: | 2011 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|